Doctor profile · Federal record
Dr. Howard Kenney, M.D.
Specialist (CMS: Rheumatology) · Spokane, WA
- NPI 1780754671
- Accepts Medicare
- 49 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
105 W 8Th Ave, Ste 6080
Spokane, WA 992042313
(509) 838-6500
fax (509) 838-6561
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- February 19, 2008
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Washington #MD00020548
- Medicaid
- WA #1005305
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780754671. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
77,449
Distinct HCPCS
10
Medicare allowed
$1,540,026
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 34,440 | 12 | $6 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 13,104 | 34 | $32 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,550 | 12 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 6,180 | 72 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 3,900 | 12 | $80 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 775 | 93 | $1 | |
80053 |
Blood test, comprehensive group of blood chemicals | 731 | 360 | $10 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 723 | 355 | $5 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 715 | 352 | $3 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 691 | 345 | $8 |
In context: peer comparison
Among 2 peers in Spokane Specialist, average services per provider: 1,034. This provider delivers 75× the peer median.Open Payments
Industry payments received
All-time total
$6,028
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ucb Sa | 7 | $1,298.14 | |
| Amgen INC. | 35 | $936.56 | |
| Alexion Pharmaceuticals, INC. | 3 | $887.51 | |
| Abbvie INC. | 31 | $793.81 | |
| Ucb, INC. | 12 | $516.36 | |
| Lilly USA, LLC | 8 | $408.11 | |
| AstraZeneca Pharmaceuticals Lp | 14 | $369.10 | |
| Novartis Pharmaceuticals Corporation | 10 | $191.98 | |
| Actelion Pharmaceuticals US, INC. | 3 | $163.43 | |
| Radius Health, INC. | 1 | $99.42 | |
| Ascendis Pharma INC | 1 | $83.19 | |
| Pfizer INC. | 10 | $80.85 | |
| Sobi, INC | 2 | $47.73 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $44.08 | |
| GlaxoSmithKline, LLC. | 2 | $42.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,040
Patients
528
Total drug cost
$426,106
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 398 | 113 | $34,048 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 284 | 54 | $9,025 |
| Prednisone | Generic | 239 | 90 | $3,166 |
| Methotrexate (Methotrexate Sodium) | Brand | 226 | 73 | $8,760 |
| Gabapentin | Generic | 148 | 34 | $3,420 |
| Meloxicam | Generic | 143 | 41 | $961 |
| Tramadol Hcl | Generic | 107 | 28 | $1,451 |
| Allopurinol | Generic | 96 | 33 | $2,616 |
| Duloxetine Hcl | Generic | 84 | 15 | $2,074 |
| Trazodone Hcl | Generic | 59 | 14 | $455 |
Frequently asked questions
What is Dr. Howard Kenney's medical specialty?
Dr. Howard Kenney practices Specialist in Spokane, WA.
Where does Dr. Howard Kenney practice?
Dr. Howard Kenney practices at 105 W 8Th Ave, Spokane, WA 992042313. Office phone: 5098386500.
What is Dr. Howard Kenney's NPI?
Dr. Howard Kenney's National Provider Identifier (NPI) is 1780754671, issued by NPPES.
Does Dr. Howard Kenney accept Medicare assignment?
Yes. Dr. Howard Kenney accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Howard Kenney commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.